Recent Posts

Cheese and Wine Good for Combating Alzheimer’s

An Iowa State University research study published in the November 2020 issue of Journal of Alzheimer’s Disease has concluded that the foods we eat may directly impact our future cognitive acuity. Headed by Auriel Willette, an assistant professor in Food Science and Human Nutrition, and Brandon Klinedinst, a Neuroscience PhD …

Read More »

Depression and Social Media

New research says that those who spend too much time on social media are apt to be depressed later on. Of course, the issue could be seen from another angle, depressed people may spend more time online, shying away from face-to-face interactions. Dr. Brian Primack, a professor of public health …

Read More »

Feeling the Nation’s Pulse

Dr. Sudha Sharma, MBBS, DGO, FRCOG, MPH, former Secretary of the Ministry of Health and Population, Nepal, is an obstetrician gynecologist and public health expert with major experiences in policy, governance, health systems, and quality of healthcare. She is a Fellow of the Royal College of Obstetricians and Gynecologists, UK, …

Read More »

HOW TO PROVE ‘HEALTH IS WEALTH’

  It is said that ‘the status of any state is reflected by its healthcare status’. At the very first glance, this sentence seems confusing and non-convincing. However, if we concentrate on the feeling encrypted in this statement for some more time, we gradually land on reality. We have been …

Read More »

New drug approvals recommended by European Medicines Agency

Roche’s Phesgo (pertuzumab/trastuzumab) is one of the half dozen medicines that the European Medicines Agency’s human medicines committee (CHMP) has recommended for approval at its November 2020 meeting. Phesgo has been endorsed as a treatment for early and metastatic breast cancer. Administered as a subcutaneous, fixed-dose combination of pertuzumab and …

Read More »

No benefit of four drugs for COVID patients, says WHO

The ongoing World Health Organization (WHO) Solidarity Trial of hydroxychloroquine, remdesivir, lopinavir, or interferon-beta-1a for the treatment of COVID-19 were found not to prevent in-hospital death, reduce need for ventilation, or shorten duration of hospitalization. The results have been published in the New England Journal of Medicine. The open-label study …

Read More »

Molnupiravir Suppresses SARS-CoV-2 Transmission Quickly

Researchers at the Institute for Biomedical Sciences, Georgia State University, have discovered that a new antiviral drug, Molnupiravir (MK-4482/EIDD-2801), completely suppresses SARS-CoV-2 transmission within 24 hours. The drug was originally found to be potent against influenza viruses. According to research team leader Dr. Richard Plemper, it is the first orally …

Read More »

Rapid Reversal of Age-related Mental Decline

A recent study has demonstrated that an experimental drug named ISRIB (integrated stress response inhibitor) rapidly restored youthful cognitive abilities in aged mice. The researchers said that ISRIB’s extremely rapid effects showed that an important component of age-related cognitive loss could be caused by reversible physiological “blockage”, rather than more …

Read More »

Major Advancement in Regenerative Medicine

  In what is a major leap forward in the advancement of regenerative therapy, scientists at Sanford Burnham Prebys Medical Discovery Institute, California, have created a drug that can lure stem cells to damaged tissue and improve treatment efficacy. The ability to instruct a stem cell to go to a …

Read More »
Sahifa Theme License is not validated, Go to the theme options page to validate the license, You need a single license for each domain name.